1.
His laboratory results were significant for an alarmingly low T cell subset count, including a relative CD4 count of 3% and an absolute count of 1 cell/mm 3 . Confirmatory tests were consistent with a diagnosis of HIV.
A bone marrow biopsy demonstrated a mildly hypercellular marrow. A bone marrow culture demonstrated Histoplasma capsulatum on day 12, 2 days after his death.
Intracellular yeast was found in the peripheral blood smear. After a histoplasma urine antigen test was found to be positive, the biopsy was reevaluated and a few foamy macrophages and tiny yeast forms were observed.
Clinical History

Patient
A 49-year-old Caucasian man from Northwest Ohio.
Chief Complaint
Diarrhea and vomiting for the previous 2 weeks, progressing to include fever and chills within the last 2 days. Additionally, he had an unintentional weight loss of 30 pounds during the previous 2 to 4 weeks and was admitted to the hospital.
Past Medical History
Bipolar disease, cocaine abuse, and alcohol abuse. (Table 1) 
Principal Laboratory Findings
Radiologic Findings
Computed tomography (CT) scan of the abdomen revealed prominent periaortic lymphadenopathy (Image 1A).
Clinical Course
The patient rapidly became hypoxic and required intubation. With an overall poor prognosis, he died within 2.5 weeks of admission.
Autopsy Findings
Autopsy revealed bilateral, diffuse pulmonary granulomas with necrosis, edema, and hemorrhage. Caseating granulomas were also present in the spleen, abdominal periaortic and thoracic perihilar lymph nodes, liver, and bone marrow. Methenamine silver staining showed 3-to 5-µm thin-walled yeast forms within the foamy macrophages in the areas of granuloma formation (Image 1B).
2. Most likely diagnosis: disseminated histoplasmosis. Our patient's clinical, radiographic, and laboratory findings are consistent with this diagnosis.
3.
Histoplasma capsulatum, a dimorphic fungus endemic to the Ohio and Mississippi river valleys, infects over 500,000 people in the United States each year with an overall prevalence of approximately 40 million cases. 1 Infection with this organism develops by inhalation of dust particles from soil contaminated with bird or bat droppings that contain the microconidia of the fungus, which subsequently germinate into yeast forms within the lungs. 2 Transmission via person to person contact has not been reported.
4.
The clinical presentation of individuals with disseminated histoplasmosis varies based upon the intensity of exposure, as well as the immune status of the individual and pre-existing pulmonary deficiency. Asymptomatic primary infection is the most common form of this disease found in those with a normal immune system. 1 With a high dose inoculum, healthy individuals may develop acute pulmonary histoplasmosis, which may include fever, headache, nonproductive cough, chills, weight loss, malaise, and myalgias. Moreover, mediastinal granulomas, pericarditis, and rheumatologic syndromes are common sequelae. Chronic pulmonary histoplasmosis is most commonly seen in those with preexisting pulmonary abnormalities, such as emphysema. Symptoms resemble those of reactivation tuberculosis and include chronic cough, dyspnea, chest pain, fatigue, fevers, and sweats. 3 In 80% of cases, disseminated histoplasmosis is seen in immunocompromised patients, 1 and has been an AIDS defining illness since 1987. 4 While HIV infection and a CD4 count of less than 200 cells/mm 3 are found typically in patients with this disease, they may instead have lymphoreticular neoplasms or be receiving corticosteroids, cytotoxic therapy, and immunosuppressive agents.
5.
While culture is the gold standard for the diagnosis of histoplasmosis infection, some isolates may require 10 to 14 days for recovery from blood culture. 5 Fungal staining of tissue and blood specimens recovers organisms in up to 70% of cases. 5 Bone marrow produces the highest yield of organisms, staining positive in up to 75% of cases of disseminated histoplasmosis. 1 Serologic detection of antigen to H. capsulatum occurs in the urine of 90% of patients and in the serum of 70% of patients with histoplasmosis. 4 6. Neutrophils, macrophages, lymphocytes, and natural killer cells are activated in response to a Histoplasma infection. Following infection with this organism, the intracellular parasite can survive within macrophages for an extended period of time. 5 Widely disseminated histoplasmosis is particularly common in immunosuppressed patients since Histoplasma infections are controlled by helper T cells that recognize the cell wall antigens of H. capsulatum organisms. Moreover, macrophages assist in spreading the organism to the adjacent lymph nodes and throughout the reticuloendothelial system (liver, spleen, lymph nodes, adrenal glands, and bone marrow).
7.
Treatment of disseminated histoplasmosis depends on HIV status and severity of disease. 4 Therapy usually requires amphotericin; however, there is evidence suggesting that itraconazole may also be effective in the treatment of this disease. 6, 7 In our patient, itraconazole therapy was chosen to minimize toxicity in this desperately ill patient. Unfortunately, the patient died 5 days after therapy was initiated, making the choice of antifungal agent moot. The survival of AIDS patients with disseminated histoplasmosis in the current era of highly effective therapy is unknown. A recent study comparing 2 amphotericin preparations reported that as many as 88% of the patients with disseminated histoplasmosis enrolled in this study had a good response to intravenous, followed by oral, itraconazole therapy. 8 However, long-term survival rates in this cohort of patients were not addressed.
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